Alexandra Leary, MD, PhD, discusses PFS and safety data from the phase 2 TEDOVA trial of Tedopi plus pembrolizumab in platinum-sensitive ovarian cancer.
Alexandra Leary, MD, PhD
Advertisement
Articles by Alexandra Leary, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
2
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
3
VIR-5500 Receives FDA Fast Track Designation in mCRPC
4
MAVERICK, B7-H3–Directed ADCs, and ADAURA Data Headline Key Lung Cancer Findings From WCLC 2026
5